Evidence map›Paper›PMID 29162603›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2018

Exogenous Insulin Infusion Can Decrease Atherosclerosis in Diabetic Rodents by Improving Lipids, Inflammation, and Endothelial Function.

Kyoungmin Park, Qian Li, Net Daş Evcimen, Christian Rask-Madsen, Yasutaka Maeda, Ernesto Maddaloni, Hisashi Yokomizo, Takanori Shinjo, Ronald St-Louis, Jialin Fu and 5 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. The Remnant Lipoprotein Hypothesis of Diabetes-Associated Cardiovascular Disease.Arteriosclerosis, thrombosis, and vascular biology · 2022
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Kyoungmin ParkFrom the Dianne Nunnally Hoppes Laboratory, Section of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA.
Qian LiFrom the Dianne Nunnally Hoppes Laboratory, Section of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA.
Net Daş EvcimenFrom the Dianne Nunnally Hoppes Laboratory, Section of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA.
Christian Rask-MadsenFrom the Dianne Nunnally Hoppes Laboratory, Section of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA.
Yasutaka MaedaFrom the Dianne Nunnally Hoppes Laboratory, Section of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA.
Ernesto MaddaloniFrom the Dianne Nunnally Hoppes Laboratory, Section of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA.
Hisashi YokomizoFrom the Dianne Nunnally Hoppes Laboratory, Section of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA.
Takanori ShinjoFrom the Dianne Nunnally Hoppes Laboratory, Section of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA.
Ronald St-LouisFrom the Dianne Nunnally Hoppes Laboratory, Section of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA.
Jialin FuFrom the Dianne Nunnally Hoppes Laboratory, Section of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA.
Daniel GordinFrom the Dianne Nunnally Hoppes Laboratory, Section of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA.
Mogher KhamaisiFrom the Dianne Nunnally Hoppes Laboratory, Section of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA.
David PoberFrom the Dianne Nunnally Hoppes Laboratory, Section of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA.
Hillary KeenanFrom the Dianne Nunnally Hoppes Laboratory, Section of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA.
George L KingFrom the Dianne Nunnally Hoppes Laboratory, Section of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA. George.king@joslin.harvard.edu.
Joslin Diabetes Center · US

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI JEAN E. SCHAFFER · 1986 to 2026
$50.5M
ROLE OF DIETARY CONSTITUENTS ON GENE EXPRESSION IN INTESTINAL EPITHELIUMP30DK040561 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI CHRISTOPHER P DUGGAN · 1994 to 2026
$31.6M
SELECTIVE INSULIN RESISTANCE--DIABETIC VASCULAR DISEASER01DK053105 · NIDDK · JOSLIN DIABETES CENTER · PI KING, GEORGE L · 1997 to 2017
$5.0M
Special BD LSRFortessaS10OD021740 · OD · JOSLIN DIABETES CENTER · PI SERWOLD, THOMAS F · 2016 to 2016
$363k
NIDDK NIH HHS P30 DK036836NIDDK NIH HHS P30 DK040561NIDDK NIH HHS R01 DK053105
6 · The paper itself

Abstract

objectiveThe objective of this study is to evaluate whether exogenously induced hyperinsulinemia may increase the development of atherosclerosis. APPROACH AND

resultsHyperinsulinemia, induced by exogenous insulin implantation in high-fat fed (60% fat HFD) apolipoprotein E-deficient mice (ApoE

conclusionsExogenous insulin decreased atherosclerosis by lowering inflammatory cytokines, macrophages, and plasma lipids in HFD-induced hyperlipidemia, insulin resistant and mildly diabetic ApoE

Indexed as

AnimalsAnti-Inflammatory AgentsAtherosclerosisBiomarkersBlood GlucoseCytokinesDiabetes MellitusDiet, High-FatDisease Models, AnimalDrug ImplantsEndothelium, VascularHypoglycemic AgentsInflammationInflammation MediatorsInsulinInsulin ResistanceAnti-Inflammatory AgentsBiomarkersBlood GlucoseCytokinesDrug ImplantsHypoglycemic AgentsInflammation MediatorsInsulinLipidsPhlorhizinatherosclerosisdiabetes mellitusendothelial dysfunctionhigh-fat diethyperglycemiainsulin resistance

Identifiers

PMID29162603
PMCPMC5791542
OpenAlexW2769675829

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.